Real-time Estimate
Cboe BZX
09:37:11 2024-03-28 am EDT
5-day change
1st Jan Change
1.255
USD
+0.40%
-6.72%
-29.78%
Presentation Operator MessageOperator (Operator)Good morning, ladies and gentlemen, and welcom...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024
Mar. 14
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 14
CI
Transcript : Protalix BioTherapeutics, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Nov. 06
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 06
CI
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M
Nov. 06
MT
HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating
23-10-31
MT
Protalix Biotherapeutics Appoints Eliot Richard Forster to Succeed Zeev Bronfeld as Chairman, Effective as of September 14, 2023
23-09-11
CI
Transcript : Protalix BioTherapeutics, Inc., Q2 2023 Earnings Call, Aug 07, 2023
23-08-07
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q2 Revenue $35.1M
23-08-07
MT
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-07
CI
Transcript : Protalix BioTherapeutics, Inc. - Special Call
23-06-27
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell Small Cap Comp Value Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 2500 Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 3000E Value Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell Small Cap Completeness Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 3000 Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 2000 Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 2000 Dynamic Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 3000E Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 3000 Value Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 2500 Value Index
23-06-23
CI
Protalix BioTherapeutics, Inc.(NYSEAM:PLX) added to Russell 2000 Value Index
23-06-23
CI
Protalix BioTherapeutics Eligible for $20 Million Milestone Payment
23-05-18
DJ
Protalix Biotherapeutics, Inc. Announces $20 Million Milestone Payment from Chiesi Global Rare Diseases
23-05-18
CI
Protalix BioTherapeutics, Chiesi Global Get FDA Approval for Elfabrio
23-05-10
DJ
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. Its ProCellEx platform is being used to manufacture approved and marketed product, Elelyso, for the treatment of Gaucher disease. The Company's ProCellEx is its proprietary platform used to produce and manufacture recombinant proteins through plant cell-based expressions in suspension. Protalix's development pipeline consists of proprietary versions of recombinant therapeutic proteins that target pharmaceutical markets, including the product candidates, such as PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase)- a chemically modified enzyme under development for the potential treatment of severe gout. PRX-119, a plant cell-expressed long action DNase I for the treatment of NETs-related diseases, and others.
More about the company
Last Close Price
1.25
USD
Average target price
13
USD
Spread / Average Target
+940.00%
Consensus
1st Jan change
Capi.
-29.78% 91.32M +9.16% 45.97B +53.63% 43.93B +11.20% 42.34B -8.59% 28.27B +16.40% 27.18B -19.34% 19.44B +13.95% 13.83B +31.56% 12.4B +10.63% 11.45B
Other Biotechnology & Medical Research
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1